To confirm the oncogenic role of PTPRO, we knocked-down the expression of PTPRO in pancreatic cancer cells using lentiviral and measured the cell viability using Celigo and flow cytometry assays, which based on GFP-expressing cancer cells. The gene discussed is PTPRO; the disease is familial pancreatic carcinoma.